Citation Impact

Citing Papers

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
High-resolution functional proteomics by active-site peptide profiling
2005
Identification and proteomic profiling of exosomes in human urine
2004 Standout
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
2015 Standout
Leptin Resistance
2008
S-Nitrosylation of β-Arrestin Regulates β-Adrenergic Receptor Trafficking
2008 StandoutNobel
Effect of pravastatin on frequency of fracture in the LIPID study: secondly analysis of a randomised controlled trial
2001
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
Diabetic retinopathy
2010 Standout
Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases
2008 StandoutNobel
Urinary Proteomics and Biomarker Discovery for Glomerular Diseases
2003
Nitric oxide synthases: regulation and function
2011 Standout
Programmed death as a therapeutic target to reduce myocardial infarction
2007
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Vasculogenesis, angiogenesis, and arteriogenesis: Mechanisms of blood vessel formation and remodeling
2007 StandoutNobel
Effect of Biliopancreatic Diversion on Hypertension in Severely Obese Patients
2005
Nitric oxide signaling in the cardiovascular system: implications for heart failure
2006
Kinin receptors in cultured rat microglia
2004
Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction
2006
Renal activity of Akt kinase in experimental Type 1 diabetes
2008
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Factors that influence the risk of hypertension in obese individuals
2003
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
2008 Standout
Meta-markers for the differential diagnosis of lung cancer and lung disease
2016
Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases
2003
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Lymphangiogenesis in development and human disease
2005 StandoutNature
Obesity-related hypertension: Is there a role for selective leptin resistance?
2004
Mitochondrial dysfunction in human pathologies
2006
Adipokines in inflammation and metabolic disease
2011 Standout
Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus
2004
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
2005
Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential
2000
Nitric oxide synthase gene therapy: progress and prospects
2009
The Role of Knee Alignment in Disease Progression and Functional Decline in Knee Osteoarthritis
2001 Standout
Angiogenesis in life, disease and medicine
2005 StandoutNature
BH4 peptide derivative from Bcl-xL attenuates ischemia/reperfusion injury thorough anti-apoptotic mechanism in rat hearts
2004
Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why)
2001
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
2006
Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury
2006
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection
2007
Obesity and Cardiovascular Disease
2009 Standout
Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering
2005 Standout
Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice
2006
Sickle-cell disease
2010 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Gene transfer as a tool to induce therapeutic vascular growth
2003
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease
2010
Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors
2005
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Myocardial Reperfusion Injury
2007 Standout
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
Quantitative reactivity profiling predicts functional cysteines in proteomes
2010 StandoutNatureNobel
Antioxidant effects of maslinic acid in livers, hearts and kidneys of streptozotocin-induced diabetic rats: effects on kidney function
2013
Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications
2005
HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an eNOS-dependent mechanism
2013
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
2006
Obesity in children and young people: a crisis in public health
2004 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Inflammatory Signals Enhance Piezo2-Mediated Mechanosensitive Currents
2012 StandoutNobel
Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
2014
Receptor Activity-modifying Proteins 2 and 3 Have Distinct Physiological Functions from Embryogenesis to Old Age
2007 StandoutNobel
Obesity and Eye Diseases
2007
Adipose Tissue as an Endocrine Organ
2004 Standout
Manipulating angiogenesis in medicine
2004
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Adrenomedullin: a new target for the design of small molecule modulators with promising pharmacological activities
2005
Isoproterenol‐induced heart failure in the rat is associated with nitric oxide‐dependent functional alterations of cardiac function
2009
The Hydrogen Sulfide Donor NaHS Promotes Angiogenesis in a Rat Model of Hind Limb Ischemia
2009
Adrenomedullin Gene Delivery Protects Against Cerebral Ischemic Injury by Promoting Astrocyte Migration and Survival
2004
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Vascular Responses to Hypoxia and Ischemia
2009 StandoutNobel
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
1995 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
2008 Standout
Hydrops Fetalis, Cardiovascular Defects, and Embryonic Lethality in Mice Lacking the Calcitonin Receptor-Like Receptor Gene
2006 StandoutNobel
Adrenomedullin--what do we know 10 years since its discovery?
2005
Novel Mechanism of Action for Hydralazine
2004
Extracellular protease activation and unraveling of the myocardial interstitium: critical steps toward clinical applications
2004
Elevated Arterial Stiffness Evaluated by Brachial-Ankle Pulse Wave Velocity is Deleterious for the Prognosis of Patients With Heart Failure
2009
Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1receptor agonists
2003
Hypoadiponectinemia Is an Independent Risk Factor for Hypertension
2004
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Adiposity and Cardiovascular Disorders
2007
Kallikrein Gene Transfer Protects Against Ischemic Stroke by Promoting Glial Cell Migration and Inhibiting Apoptosis
2003
Cardiac Energy Metabolism in Obesity
2007
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Mechanisms of Diabetic Complications
2013 Standout
The Metabolic Syndrome
2008 Standout
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Leptin and Cardiovascular Disease
2008
Role of the B 1 Kinin Receptor in the Regulation of Cardiac Function and Remodeling After Myocardial Infarction
2005
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Inhibition of hypoxia‐induced angiogenesis by cigarette smoke exposure: impairment of the HIF‐lalpha/VEGF pathway
2003
Myocardial AKT: The Omnipresent Nexus
2011
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Physiology of Microglia
2011 Standout

Works of Jun Agata being referenced

Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury
2001
Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction
2005
Effects of the Chinese Medicine TSJN on Insulin Resistance and Hypertension in Fructose-Fed Rats.
2000
Overexpression of Kinin B1 Receptors Induces Hypertensive Response to Des-Arg9-bradykinin and Susceptibility to Inflammation
2002
High Plasma Immunoreactive Leptin Level in Essential Hypertension
1997
Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme
2006
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure
2000
Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty
2003
Kallikrein Gene Delivery Improves Cardiac Reserve and Attenuates Remodeling After Myocardial Infarction
2002
Kallistatin is a new inhibitor of angiogenesis and tumor growth
2002
Bradykinin B 1 Receptor Mediates Inhibition of Neointima Formation in Rat Artery After Balloon Angioplasty
2000
Angiotensin II Receptor Blocker Prevents Increased Arterial Stiffness in Patients With Essential Hypertension
2004
Role of Hyperinsulinemia in Atherosclerotic Coronary Arterial Disease. Studies of Semi-quantitative Coronary Angiography.
1999
Kallikrein Gene Delivery Improves Serum Glucose and Lipid Profiles and Cardiac Function in Streptozotocin-Induced Diabetic Rats
2005
Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion
2003
Human Endothelial Nitric Oxide Synthase Gene Delivery Promotes Angiogenesis in a Rat Model of Hindlimb Ischemia
2002
Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats
2002
Rankless by CCL
2026